Episode 078: Management of relapsed diffuse l...

This week, we put everything we talked about in our ITP series together and talk about how we manage ITP in complicated patient scenarios. Through a case-based discussion, we discuss how to we would approach each of these complicated scenarios. If you haven’t done so already, be ...  Show more

This week, we move to the relapsed/refractory ITP setting, focusing on what options are available to patients after their initial treatment with steroids ± IVIg, which we discussed in Episode 155. If you have not done so already, definitely listen to that episode as we build on t ...  Show more

How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024.
  
Credit available for this activity expires: 07/31/25
Earn Credit / Learning Obje ...

This week’s episode will be focusing on one of the Non-Hodgkin Lymphomas: Follicular Lymphoma. We will go over the important details on diagnostic criteria, indications for treatment and treatment options.

In the final episode from the Hematology and Oncology chapter of Crush Step 1, we discuss: - Myeloproliferative Disorders - Disorders of Heme Production - Pharmacologic Treatment Learn more about your ad choices. Visit megaphone.fm/adchoices 

In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma presented at the recent EHA and ICML meetings in June 2025. The episode focuses primarily on the emerging role of bispecific anti ...  Show more